Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB-231 breast tumor models

Journal of Lipid Research

Volumn 54, Issue 2, 2013, Pages 333-344

  Chughtai, Kamila ^a   Jiang, Lu ^b   Greenwood, Tiffany R ^b   Glunde, Kristine ^b   Heeren, Ron M A ^a,c  

^a FOM INSTITUTE AMOLF   (Netherlands)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

Author keywords

Mass spectrometry; Matrix assisted laser desorption ionization; Multimodal imaging; Phospholipids

Indexed keywords

ACYLCARNITINE; PALMITOYLCARNITINE; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN; STEAROYLCARNITINE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID COMPOSITION; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION MASS SPECTROMETRY; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; SEPARATION TECHNIQUE; TISSUE DISTRIBUTION; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CARNITINE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MASS SPECTROMETRY; MICE; MOLECULAR IMAGING; PHOSPHATIDYLCHOLINES; SPHINGOMYELINS;

EID: 84872463336     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M027961     Document Type: Article

References (77)

1. Chughtai, K., and R. M. Heeren. 2010. Mass spectrometric imaging for biomedical tissue analysis. Chem. Rev. 110: 3237-3277.
2. Vaupel, P., A. Mayer, S. Briest, and M. Hockel. 2003. Oxygenation gain factor: a novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers. Cancer Res. 63: 7634-7637. (Pubitemid 37466687)
3. Hoogsteen, I. J., H. A. Marres, F. J. van den Hoogen, P. F. Rijken, J. Lok, J. Bussink, and J. H. Kaanders. Expression of EGFR under tumor hypoxia: identification of a subpopulation of tumor cells responsible for aggressiveness and treatment resistance. Int. J. Radiat. Oncol. Biol. Phys. Epub ahead of print. March 13, 2012; doi: 10.1016/j.ijrobp.2012.01.002.
4. Vaupel, P., and A. Mayer. 2007. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 26: 225-239. (Pubitemid 47101660)
5. Morton, C. L., and P. J. Houghton. 2007. Establishment of human tumor xenografts in immunodeficient mice. Nat. Protoc. 2: 247-250. (Pubitemid 47040037)
6. Kakkad, S. M., M. Solaiyappan, B. O'Rourke, I. Stasinopoulos, E. Ackerstaff, V. Raman, Z. M. Bhujwalla, and K. Glunde. 2010. Hypoxic tumor microenvironments reduce collagen I fiber density. Neoplasia. 12: 608-617.
7. Penet, M. F., A. P. Pathak, V. Raman, P. Ballesteros, D. Artemov, and Z. M. Bhujwalla. 2009. Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft. Cancer Res. 69: 8822-8829.
8. Hart, P. J., S. Francese, E. Claude, M. N. Woodroofe, and M. R. Clench. 2011. MALDI-MS imaging of lipids in ex vivo human skin. Anal. Bioanal. Chem. 401: 115-125.
9. Tanaka, H., N. Zaima, N. Yamamoto, D. Sagara, M. Suzuki, M. Nishiyama, Y. Mano, M. Sano, T. Hayasaka, N. Goto-Inoue, et al. 2010. Imaging mass spectrometry reveals unique lipid distribution in primary varicose veins. Eur. J. Vasc. Endovasc. Surg. 40: 657-663.
10. Meriaux, C., J. Franck, M. Wisztorski, M. Salzet, and I. Fournier. 2010. Liquid ionic matrixes for MALDI mass spectrometry imaging of lipids. J. Proteomics. 73: 1204-1218.
11. Burnum, K. E., D. S. Cornett, S. M. Puolitaival, S. B. Milne, D. S. Myers, S. Tranguch, H. A. Brown, S. K. Dey, and R. M. Caprioli. 2009. Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation. J. Lipid Res. 50: 2290-2298.
12. Enomoto, H., Y. Sugiura, M. Setou, and N. Zaima. 2011. Visualization of phosphatidylcholine, lysophosphatidylcholine and sphingomyelin in mouse tongue body by matrix-assisted laser desorption/ionization imaging mass spectrometry. Anal. Bioanal. Chem. 400: 1913-1921.
13. Touboul, D., H. Piednoel, V. Voisin, S. De La Porte, A. Brunelle, F. Halgand, and O. Laprevote. 2004. Changes of phospholipid composition within the dystrophic muscle by matrix-assisted laser desorption/ionization mass spectrometry and mass spectrometry imaging. Eur. J. Mass Spectrom. (Chichester, Eng.). 10: 657-664. (Pubitemid 39611657)
14. Chughtai, S., K. Chughtai, B. Cillero-Pastor, A. Kiss, P. Agrawal, L. MacAleese, and R. M. A. Heeren. 2012. A multimodal mass spectrometry imaging approach for the study of musculoskeletal tissues. Int. J. Mass Spectrom. 325-327: 150-160.
15. Landgraf, R. R., M. C. Prieto Conaway, T. J. Garrett, P. W. Stacpoole, and R. A. Yost. 2009. Imaging of lipids in spinal cord using intermediate pressure matrix-assisted laser desorption-linear ion trap/Orbitrap MS. Anal. Chem. 81: 8488-8495.
16. Menger, R. F., W. L. Stutts, D. S. Anbukumar, J. A. Bowden, D. A. Ford, and R. A. Yost. 2012. MALDI mass spectrometric imaging of cardiac tissue following myocardial infarction in a rat coronary artery ligation model. Anal. Chem. 84: 1117-1125.
17. Astigarraga, E., G. Barreda-Gomez, L. Lombardero, O. Fresnedo, F. Castano, M. T. Giralt, B. Ochoa, R. Rodriguez-Puertas, and J. A. Fernandez. 2008. Profiling and imaging of lipids on brain and liver tissue by matrix-assisted laser desorption/ ionization mass spectrometry using 2-mercaptobenzothiazole as a matrix. Anal. Chem. 80: 9105-9114.
18. Cha, S., and E. S. Yeung. 2007. Colloidal graphite-assisted laser desorption/ionization mass spectrometry and MSn of small molecules. 1. Imaging of cerebrosides directly from rat brain tissue. Anal. Chem. 79: 2373-2385. (Pubitemid 46449019)
19. Koizumi, S., S. Yamamoto, T. Hayasaka, Y. Konishi, M. Yamaguchi-Okada, N. Goto-Inoue, Y. Sugiura, M. Setou, and H. Namba. 2010. Imaging mass spectrometry revealed the production of lyso-phosphatidylcholine in the injured ischemic rat brain. Neuroscience. 168: 219-225.
20. Puolitaival, S. M., K. E. Burnum, D. S. Cornett, and R. M. Caprioli. 2008. Solvent-free matrix dry-coating for MALDI imaging of phospholipids. J. Am. Soc. Mass Spectrom. 19: 882-886.
21. Trim, P. J., S. J. Atkinson, A. P. Princivalle, P. S. Marshall, A. West, and M. R. Clench. 2008. Matrix-assisted laser desorption/ionisation mass spectrometry imaging of lipids in rat brain tissue with integrated unsupervised and supervised multivariant statistical analysis. Rapid Commun. Mass Spectrom. 22: 1503-1509. (Pubitemid 351829691)
22. Wang, H. Y., S. N. Jackson, J. Post, and A. S. Woods. 2008. A minimalist approach to MALDI imaging of glycerophospholipids and sphingolipids in rat brain sections. Int. J. Mass Spectrom. 278: 143-149.
23. Chen, Y., J. Allegood, Y. Liu, E. Wang, B. Cachon-Gonzalez, T. M. Cox, A. H. Merrill, Jr., and M. C. Sullards. 2008. Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease. Anal. Chem. 80: 2780-2788. (Pubitemid 351556439)
24. Murphy, R. C., J. A. Hankin, and R. M. Barkley. 2009. Imaging of lipid species by MALDI mass spectrometry. J. Lipid Res. 50 (Suppl.): 317-322.
25. Veloso, A., E. Astigarraga, G. Barreda-Gomez, I. Manuel, I. Ferrer, M. T. Giralt, B. Ochoa, O. Fresnedo, R. Rodriguez-Puertas, and J. A. Fernandez. 2011. Anatomical distribution of lipids in human brain cortex by imaging mass spectrometry. J. Am. Soc. Mass Spectrom. 22: 329-338.
26. Veloso, A., R. Fernandez, E. Astigarraga, G. Barreda-Gomez, I. Manuel, M. T. Giralt, I. Ferrer, B. Ochoa, R. Rodriguez-Puertas, and J. A. Fernandez. 2011. Distribution of lipids in human brain. Anal. Bioanal. Chem. 401: 89-101.
27. Eberlin, L. S., I. Norton, A. L. Dill, A. J. Golby, K. L. Ligon, S. Santagata, R. G. Cooks, and N. Y. Agar. 2012. Classifying human brain tumors by lipid imaging with mass spectrometry. Cancer Res. 72: 645-654.
28. Masterson, T. A., A. L. Dill, L. S. Eberlin, M. Mattarozzi, L. Cheng, S. D. Beck, F. Bianchi, and R. G. Cooks. 2011. Distinctive glycerophospholipid profiles of human seminoma and adjacent normal tissues by desorption electrospray ionization imaging mass spectrometry. J. Am. Soc. Mass Spectrom. 22: 1326-1333.
29. Gustafsson, J. O., M. K. Oehler, A. Ruszkiewicz, S. R. McColl, and P. Hoffmann. 2011. MALDI imaging mass spectrometry (MALDI-IMS) - application of spatial proteomics for ovarian cancer classification and diagnosis. Int. J. Mol. Sci. 12: 773-794.
30. Liu, Y., Y. Chen, A. Momin, R. Shaner, E. Wang, N. J. Bowen, L. V. Matyunina, L. D. Walker, J. F. McDonald, M. C. Sullards, et al. 2010. Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry. Mol. Cancer. 9: 186.
31. Willems, S. M., A. van Remoortere, R. van Zeijl, A. M. Deelder, L. A. McDonnell, and P. C. Hogendoorn. 2010. Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity. J. Pathol. 222: 400-409.
32. Eberlin, L. S., A. L. Dill, A. J. Golby, K. L. Ligon, J. M. Wiseman, R. G. Cooks, and N. Y. Agar. 2010. Discrimination of human astrocytoma subtypes by lipid analysis using desorption electrospray ionization imaging mass spectrometry. Angew. Chem. Int. Ed. Engl. 49: 5953-5956.
33. Eberlin, L. S., A. L. Dill, A. B. Costa, D. R. Ifa, L. Cheng, T. Masterson, M. Koch, T. L. Ratliff, and R. G. Cooks. 2010. Cholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometry. Anal. Chem. 82: 3430-3434.
34. Shimma, S., Y. Sugiura, T. Hayasaka, Y. Hoshikawa, T. Noda, and M. Setou. 2007. MALDI-based imaging mass spectrometry revealed abnormal distribution of phospholipids in colon cancer liver metastasis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 855: 98-103. (Pubitemid 47077722)
35. Dill, A. L., D. R. Ifa, N. E. Manicke, Z. Ouyang, and R. G. Cooks. 2009. Mass spectrometric imaging of lipids using desorption electrospray ionization. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 2883-2889.
36. Le, T. T., T. B. Huff, and J. X. Cheng. 2009. Coherent anti-Stokes Raman scattering imaging of lipids in cancer metastasis. BMC Cancer. 9: 42.
37. Ramos, C. V., and H. B. Taylor. 1974. Lipid-rich carcinoma of the breast. A clinicopathologic analysis of 13 examples. Cancer. 33: 812-819.
38. Sijens, P. E., P. C. Levendag, C. J. Vecht, P. van Dijk, and M. Oudkerk. 1996. 1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors. NMR Biomed. 9: 65-71. (Pubitemid 26352495)
39. Folick, A., W. Min, and M. C. Wang. 2011. Label-free imaging of lipid dynamics using coherent anti-Stokes Raman scattering (CARS) and stimulated Raman scattering (SRS) microscopy. Curr. Opin. Genet. Dev. 21: 585-590.
40. Le, T. T., S. Yue, and J. X. Cheng. 2010. Shedding new light on lipid biology with coherent anti-Stokes Raman scattering microscopy. J. Lipid Res. 51: 3091-3102.
41. Maier, O., V. Oberle, and D. Hoekstra. 2002. Fluorescent lipid probes: some properties and applications (a review). Chem. Phys. Lipids. 116: 3-18. (Pubitemid 34686984)
42. Krishnamachary, B., M. F. Penet, S. Nimmagadda, Y. Mironchik, V. Raman, M. Solaiyappan, G. L. Semenza, M. G. Pomper, and Z. M. Bhujwalla. Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer. PLoS ONE. Epub August 28, 2012; doi: 10.1371/journal.pone. 0044078.
43. Jiang, L., T. R. Greenwood, D. Artemov, V. Raman, P. T. Winnard, Jr., R. M. A. Heeren, Z. M. Bhujwalla, and K. Glunde. 2012. Localized hypoxia results in spatially heterogeneous metabolic signatures in breast tumor models. Neoplasia. 14: 732-741.
44. Jiang, L., T. R. Greenwood, E. R. Amstalden van Hove, K. Chughtai, V. Raman, P. T. Winnard, Jr., R. M. A. Heeren, D. Artemov, and K. Glunde. 2012. Combined MR, fluorescence and histology imaging strategy in a human breast tumor xenograft model. NMR Biomed. Epub ahead of print. September 4, 2012. doi: 10.1002/nbm.2846.
45. Chughtai, K., L. Jiang, T. R. Greenwood, I. Klinkert, E. R. Amstalden van Hove, R. M. Heeren, and K. Glunde. 2012. Fiducial markers for combined 3-dimensional mass spectrometric and optical tissue imaging. Anal. Chem. 84: 1817-1823.
46. Fahy, E., S. Subramaniam, R. C. Murphy, M. Nishijima, C. R. Raetz, T. Shimizu, F. Spener, G. van Meer, M. J. Wakelam, and E. A. Dennis. 2009. Update of the LIPID MAPS comprehensive classification system for lipids. J. Lipid Res. 50 (Suppl.): 9-14.
47. Fahy, E., M. Sud, D. Cotter, and S. Subramaniam. 2007. LIPID MAPS online tools for lipid research. Nucleic Acids Res. 35: W606-612.
48. Cootes, T. F., C. J. Taylor, D. H. Cooper, and J. Graham. 1995. Active shape models - their training and application. Comput. Vis. Image Underst. 61: 38-59.
49. Peterson, B. L., and B. S. Cummings. 2006. A review of chromatographic methods for the assessment of phospholipids in biological samples. Biomed. Chromatogr. 20: 227-243.
50. Watson, A. D. 2006. Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J. Lipid Res. 47: 2101-2111. (Pubitemid 44936121)
51. Jackson, S. N., M. Ugarov, J. D. Post, T. Egan, D. Langlais, J. A. Schultz, and A. S. Woods. 2008. A study of phospholipids by ion mobility TOFMS. J. Am. Soc. Mass Spectrom. 19: 1655-1662.
52. Jackson, S. N., M. Ugarov, T. Egan, J. D. Post, D. Langlais, J. Albert Schultz, and A. S. Woods. 2007. MALDI-ion mobility-TOFMS imaging of lipids in rat brain tissue. J. Mass Spectrom. 42: 1093-1098. (Pubitemid 47255461)
53. Snel, M. F., and M. Fuller. 2010. High-spatial resolution matrix-assisted laser desorption ionization imaging analysis of glucosylceramide in spleen sections from a mouse model of Gaucher disease. Anal. Chem. 82: 3664-3670.
54. Petkovic, M., J. Schiller, M. Muller, S. Benard, S. Reichl, K. Arnold, and J. Arnhold. 2001. Detection of individual phospholipids in lipid mixtures by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: phosphatidylcholine prevents the detection of further species. Anal. Biochem. 289: 202-216. (Pubitemid 32173668)
55. Estrada, R., and M. C. Yappert. 2004. Alternative approaches for the detection of various phospholipid classes by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J. Mass Spectrom. 39: 412-422. (Pubitemid 38515355)
56. Arnhold, J., A. N. Osipov, H. Spalteholz, O. M. Panasenko, and J. Schiller. 2002. Formation of lysophospholipids from unsaturated phosphatidylcholines under the influence of hypochlorous acid. Biochim. Biophys. Acta. 1572: 91-100. (Pubitemid 35223060)
57. Wang, H. Y., C. B. Liu, H. W. Wu, and J. S. Kuo. 2010. Direct profiling of phospholipids and lysophospholipids in rat brain sections after ischemic stroke. Rapid Commun. Mass Spectrom. 24: 2057-2064.
58. Goetzl, E. J., H. Dolezalova, Y. Kong, and L. Zeng. 1999. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells. Cancer Res. 59: 4732-4737. (Pubitemid 29428984)
59. Imai, A., T. Furui, T. Tamaya, and G. B. Mills. 2000. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells. J. Clin. Endocrinol. Metab. 85: 3370-3375.
60. Spiegelberg, B. D., and H. E. Hamm. 2007. Roles of G-protein-coupled receptor signaling in cancer biology and gene transcription. Curr. Opin. Genet. Dev. 17: 40-44. (Pubitemid 46109292)
61. Umezu-Goto, M., J. Tanyi, J. Lahad, S. Liu, S. Yu, R. Lapushin, Y. Hasegawa, Y. Lu, R. Trost, T. Bevers, et al. 2004. Lysophosphatidic acid production and action: validated targets in cancer? J. Cell. Biochem. 92: 1115-1140. (Pubitemid 44264223)
62. Modrak, D. E., D. V. Gold, and D. M. Goldenberg. 2006. Sphingolipid targets in cancer therapy. Mol. Cancer Ther. 5: 200-208.
63. Augé, N., F. Maupas-Schwalm, M. Elbaz, J. C. Thiers, A. Waysbort, S. Itohara, H. W. Krell, R. Salvayre, and A. Negre-Salvayre. 2004. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation. 110: 571-578. (Pubitemid 39031175)
64. Zeidan, Y. H., and Y. A. Hannun. 2010. The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation. Curr. Mol. Med. 10: 454-466.
65. Signorelli, P., and R. Ghidoni. 2005. Breast cancer and sphingolipid signalling. J. Dairy Res. 72: 5-13. (Pubitemid 41323090)
66. Momin, A. A., H. Park, B. J. Portz, C. A. Haynes, R. L. Shaner, S. L. Kelly, I. K. Jordan, and A. H. Merrill, Jr. 2011. A method for visualization of "omic" datasets for sphingolipid metabolism to predict potentially interesting differences. J. Lipid Res. 52: 1073-1083.
67. Chalfant, C. E., and S. Spiegel. 2005. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J. Cell Sci. 118: 4605-4612. (Pubitemid 41646371)
68. Pettus, B. J., A. Bielawska, P. Subramanian, D. S. Wijesinghe, M. Maceyka, C. C. Leslie, J. H. Evans, J. Freiberg, P. Roddy, Y. A. Hannun, et al. 2004. Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J. Biol. Chem. 279: 11320-11326. (Pubitemid 38401629)
69. Kerner, J., and C. Hoppel. 2000. Fatty acid import into mitochondria. Biochim. Biophys. Acta. 1486: 1-17. (Pubitemid 30336788)
70. Das, D. K., J. Ayromlooi, and A. Neogi. 1983. Effect of ischemia on fatty acid metabolism in fetal lung. Life Sci. 33: 569-576. (Pubitemid 13072914)
71. Yamada, K. A., J. McHowat, G. X. Yan, K. Donahue, J. Peirick, A. G. Kleber, and P. B. Corr. 1994. Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia. Circ. Res. 74: 83-95.
72. Bruder, E. D., and H. Raff. 2010. Cardiac and plasma lipid profiles in response to acute hypoxia in neonatal and young adult rats. Lipids Health Dis. 9: 3.
73. Hütter, J. F., C. Alves, and S. Soboll. 1990. Effects of hypoxia and fatty acids on the distribution of metabolites in rat heart. Biochim. Biophys. Acta. 1016: 244-252.
74. Whitmer, J. T., J. A. Idell-Wenger, M. J. Rovetto, and J. R. Neely. 1978. Control of fatty acid metabolism in ischemic and hypoxic hearts. J. Biol. Chem. 253: 4305-4309. (Pubitemid 8380657)
75. Wainwright, M. S., R. Kohli, P. F. Whitington, and D. H. Chace. 2006. Carnitine treatment inhibits increases in cerebral carnitine esters and glutamate detected by mass spectrometry after hypoxia-ischemia in newborn rats. Stroke. 37: 524-530. (Pubitemid 43732018)
76. McHowat, J., K. A. Yamada, J. E. Saffitz, and P. B. Corr. 1993. Subcellular distribution of endogenous long chain acylcarnitines during hypoxia in adult canine myocytes. Cardiovasc. Res. 27: 1237-1243. (Pubitemid 23250903)
77. Meyburg, J., A. Schulze, D. Kohlmueller, O. Linderkamp, and E. Mayatepek. 2001. Postnatal changes in neonatal acylcarnitine profile. Pediatr. Res. 49: 125-129. (Pubitemid 32015010)